Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



5 More Stocks That More Than Doubled in 2011

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Despite the market's flattish performance last year, there were still roughly two dozen companies that managed to more than double in 2011.

I went over five of the more prolific winners earlier this week, but now it's time to turn my attention to five more publicly traded companies that made investors a whole lot of money last year.

Silicon Motion (Nasdaq: SIMO  ) -- up 382%
The market's second-biggest winner -- nearly a five-bagger over the past 12 months -- is a chip company riding the hot trends of flash memory and mobile communications.

Don't let anyone tell you that semiconductors are boring.

Analysts see Silicon Motion's earnings nearly tripling for all of 2011 on a 64% top-line surge. It has also blown past Wall Street's profit targets by at least 38% over the past year. Racking up stellar growth and greatly surpassing expectations are a one-two punch for beating the market.

Medivation (Nasdaq: MDVN  ) -- up 204%
Medivation took off after posting promising news on a late-stage trial for its MDV3100 prostate drug two months ago.

The biotech revealed that prostate cancer patients on the oral medication lived an average of five months longer than those who didn't take it.

Golar LNG (Nasdaq: GLNG  ) -- up 196%
The LNG in Golar's name stands for "liquefied natural gas," and despite its small fleet, the speculative nature of LNG helped fuel the stock to nearly a triple.

There are valid valuation concerns when it comes to Golar LNG, but opportunities including Japan, where LNG helped fill the energy gap when some of the country's nuclear reactors were being repaired, will keep this volatile player interesting.

Oncothyreon (Nasdaq: ONTY  ) -- up 133%
The biotech company has a few cancer-battling drugs in development, backed by no shortage of believers. An immunotherapy called Stimuvax is in the third and final clinical trial stage as a treatment for lung cancer patients.

The stock was already doing well in November when a Wedbush Morgan analyst issued an upbeat note and a juicy $31 price target on the shares.

Sturm, Ruger (NYSE: RGR  ) -- up 130%
Firearms may not seem like a dynamic growth industry, but Sturm, Ruger managed to grow revenue by 37% in its latest quarter.

Sturm, Ruger has also been blowing away analyst profit targets consistently over the past year. Yes, that was a double shot of puns in that last sentence -- and I guess "double shot" makes three.

Abner Doubelday lives
Few figured that selling firearms or alternative energy would be the ticket to market-thumping returns in 2011. The year ahead will also offer some intriguing if not unlikely victors.

Motley Fool's top stock for 2012 almost doubled in 2011, soaring 85% in an otherwise ho-hum year. If you want to see why we think it's going to have another strong year, the free report is all yours.

Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Longtime Fool contributor Rick Munarriz calls them as he sees them. He owns no shares in any of the stocks in this story and is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1754160, ~/Articles/ArticleHandler.aspx, 10/28/2016 4:12:21 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,161.05 -8.63 -0.05%
S&P 500 2,126.50 -6.54 -0.31%
NASD 5,188.52 -27.45 -0.53%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/28/2016 3:56 PM
GLNG $22.58 Down -0.98 -4.16%
Golar LNG CAPS Rating: *****
MDVN $0.00 Down +0.00 +0.00%
Medivation CAPS Rating: ****
ONTY.DL $1.06 Down -0.02 -1.85%
Oncothyreon CAPS Rating: ****
RGR $59.35 Up +0.45 +0.76%
Sturm, Ruger and C… CAPS Rating: ****
SIMO $40.54 Down -5.87 -12.65%
Silicon Motion Tec… CAPS Rating: ***